Drugs / 50 mg/m² iv every 4 weeks until confirmed evidence of disease progression
50 mg/m² iv every 4 weeks until confirmed evidence of disease progression
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01358071 | Jun 2011 → Dec 2016 | ovarian cancer | AGC Biologics S.p.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 50 mg/m² iv every 4 weeks until confirmed evidence of disease progression | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01358071 ↗ |
| Route | Intravenous | “50 mg/m² iv” NCT01358071 ↗ |